New tests aim to spot bone marrow graft failure early
NCT ID NCT03541889
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing two new ways to check if donated bone marrow cells are growing well after a transplant. Researchers will use a special PET scan (FLT imaging) and blood tests (TK1 levels) in about 56 people who are at high risk for graft failure. The goal is to find better tools to detect problems early, so doctors can act quickly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- FLT imaging and TK1 blood measurements
- What this could lead to
- If successful, these tests could help doctors quickly tell if a bone marrow transplant is working, allowing earlier treatment for graft failure.
- What could go wrong
- This is a small, early-phase pilot study (56 people) testing new methods, so results may not apply broadly or lead to a proven test.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY GRAFT FAILURE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
-
University Hospital of Cleveland UH Seidman Cancer Center
NOT_YET_RECRUITINGCleveland, Ohio, 44106, United States
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
University of Oklahoma Health Sciences Center, Stephenson Cancer Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.